DEA Schedules Four Ridiculous Synthetic Drug Names in Schedule I
Published Date: 5/1/2026
Rule
Summary
Starting May 1, 2026, the DEA officially puts four new substances—4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA—into Schedule I, meaning they’re now illegal to make, sell, or use without special permission. This affects anyone handling these chemicals, including researchers and businesses, who must follow strict rules or face serious penalties. The move aims to keep communities safer by cracking down on these risky drugs.
Analyzed Economic Effects
6 provisions identified: 1 benefits, 4 costs, 1 mixed.
Four Chemicals Placed in Schedule I
Starting May 1, 2026, DEA permanently places 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I. That means making, distributing, importing, exporting, or possessing these substances is unlawful without DEA authorization and persons who handle them face administrative, civil, and criminal sanctions.
Registration Required to Handle Substances
Any person who handles or wants to handle these four substances must register with DEA under 21 U.S.C. 822, 823, 957, and 958 and the implementing regulations. Persons who currently handle them and are not registered may not continue to handle them as of May 1, 2026.
Research Continuation Window and Hearing Timelines
If on May 1, 2026 you are registered to conduct research with another Schedule I substance, you may continue research on these four substances only if you submit a completed registration or modification application within 90 calendar days after May 1, 2026. If DEA serves an order to show cause proposing denial, you may request a hearing which will be held on an expedited basis and not later than 45 calendar days after the request unless you ask for a later date.
Compliance Rules: Security, Inventory, and Reporting
Registered handlers must follow Schedule I controls: meet security requirements, complete initial inventories on the date they first handle these substances, take inventories every two years, comply with labeling and packaging rules, submit required records and reports (including to the Automation of Reports and Consolidated Order System), and use required order forms for distribution.
Disposal Requirement for Unregistered Holders
If you are unwilling or unable to obtain a Schedule I registration, you must surrender or transfer all quantities you hold of these substances to a DEA-registered person before the effective date (May 1, 2026) and dispose of them in accordance with 21 CFR part 1317 and applicable laws.
DEA Certifies Little Small-Entity Economic Impact
DEA states, under the Regulatory Flexibility Act, that this final rule will not have a significant economic impact on a substantial number of small entities.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-09566 — Schedules of Controlled Substances: Placement of CUMYL-PEGACLONE in Schedule I
Starting May 13, 2026, the DEA officially puts CUMYL-PEGACLONE—a chemical that can be risky—into Schedule I, the strictest drug category. This means anyone making, selling, or using it now faces tough rules and penalties. This move helps the U.S. follow international drug laws and keeps communities safer without any new fees or costs.
2026-08595 — Specific Listing for Hexahydrocannabinol, A Currently Controlled Schedule I Substance
The DEA is giving hexahydrocannabinol (HHC) its own official spot on the list of Schedule I drugs, making it clear that HHC is controlled separately from other similar substances. This change starts May 4, 2026, and affects anyone making, selling, or using HHC, which stays illegal under federal law. No new fees or costs are introduced, but the update helps law enforcement and businesses know exactly where HHC stands.
2026-08588 — Bulk Manufacturer of Controlled Substances Application: Patheon API Inc.
Patheon API Inc. wants to make large amounts of special research drugs like dimethyltryptamine and psilocybin. This affects researchers and companies involved in clinical trials, with a chance to comment or ask for a hearing by July 6, 2026. No money changes are mentioned, but this move could speed up important medical studies.
2026-08587 — Importer of Controlled Substances Application: ANI Pharmaceuticals Inc.
ANI Pharmaceuticals wants to import certain controlled drugs like Levorphanol and Tapentadol. People who make or use these drugs can share their thoughts or ask for a hearing by June 3, 2026. This move could affect drug availability and regulation, so keep an eye on the deadline to have your say!
2026-08176 — Schedules of Controlled Substances: Rescheduling of Food and Drug Administration Approved Products Containing Marijuana From Schedule I to Schedule III; Corresponding Change to Permit Requirements
Starting April 28, 2026, FDA-approved marijuana-based medicines move from the strictest drug category (Schedule I) to a less strict one (Schedule III). This change helps medical marijuana businesses get faster federal permits to make and sell these products legally. If you have a state medical marijuana license, you’ll find it easier and quicker to work with these medicines under new federal rules.
2026-08177 — Schedules of Controlled Substances: Rescheduling of Marijuana
The DEA is planning to move marijuana to Schedule III, which means it’s seen as less risky and easier to use medically. This change affects patients, doctors, and businesses, making marijuana more accessible and possibly boosting the market. A public hearing starts June 29, 2026, with chances to join by May 28, so get ready to have your say!
Previous / Next Documents
Previous: 2026-08515 — Overweight and Oversize Items Fee Application
Starting July 12, 2026, the Postal Service will charge a $200 fee for overweight or oversize items found in the mail system or reported in shipping manifests. This fee applies to both retail and commercial mailers, except for items caught and returned during retail transactions. Mailers must pay the fee before their item is released, so watch your package size and weight!
Next: 2026-08533 — Pacific Halibut Fisheries of the West Coast; 2026 Catch Sharing Plan and Recreational Fishery Management Measures
Starting April 30, 2026, new rules will change how Pacific halibut fishing works off Washington, Oregon, and California. These updates share the catch fairly and set fun fishing season dates to protect halibut while giving anglers more chances to reel them in. If you fish recreationally, get ready for new limits and areas to keep the halibut population healthy and the fishing exciting!